PROCEPT BioRobotics (PRCT) Share-based Compensation (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Share-based Compensation for 7 consecutive years, with $14.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 19.49% year-over-year to $14.5 million in Q2 2026; TTM through Jun 2026 was $52.9 million, a 32.78% increase from a year earlier, with the FY2025 full-year figure at $47.6 million, up 49.51% from the prior year.
• Share-based Compensation was $14.5 million for Q2 2026 at PROCEPT BioRobotics, up from $13.1 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $18.4 million in Q3 2022 and troughed at $186000.0 in Q4 2022.
• A 5-year average of $8.3 million and a median of $8.2 million in 2024 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation sank 87.57% in 2022 and surged 2577.96% in 2023, its largest moves.
• Over 5 years, Share-based Compensation stood at $186000.0 in 2022, then surged by 2577.96% to $5.0 million in 2023, then surged by 82.39% to $9.1 million in 2024, then grew by 19.34% to $10.8 million in 2025, then surged by 34.05% to $14.5 million in 2026.
• The last three Share-based Compensation figures came in at $14.5 million (Q2 2026), $13.1 million (Q1 2026), and $10.8 million (Q4 2025), per Business Quant data.